InvestorsHub Logo
Followers 272
Posts 21703
Boards Moderated 1
Alias Born 10/01/2004

Re: Doubleday post# 174

Monday, 01/11/2021 8:34:24 PM

Monday, January 11, 2021 8:34:24 PM

Post# of 385
up 10% after hours $THMO ThermoGenesis (THMO) is a microcap that has developed a superior platform for sorting out specific immune cells from blood samples using Buoyancy Activated Cell Sorting (X-BACS) technology. This innovative technology uses microbubbles that attach to the target cells and gently float them to the top of a test tube with minimal stress. This product line is designed to facilitate research in immunotherapies, such as CAR-T, and represents big improvement over existing methods. Corning Life Sciences paid ThermoGenesis $2,000,000 for distribution rights in September 2019 and finally launched a marketing campaign in July 2020 under the Corning (GLW) name. The Corning X-SERIES® Cell Separation Platform has been featured on the company's home page for months and a revenue ramp-up for tiny ThermoGenesis should kick in this year.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THMO News